ArticleHaematologica2025

Tyrosine kinase inhibitor discontinuation in nonallografted Philadelphia-positive acute lymphoblastic leukemia patients: a Campus ALL real-life study.

Matteo Dragani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.